Result of Secondary Placing in Standard Life plc

Summary by AI BETAClose X

Aberdeen Group PLC has completed a secondary placing of 52,000,000 ordinary shares in Standard Life plc, representing approximately 5.2% of Standard Life's issued share capital, at a price of 839 pence per share, generating gross proceeds of approximately £436 million. Following this transaction, Aberdeen's remaining stake in Standard Life will also be approximately 5.2%. The company intends to use these proceeds to maintain a strong balance sheet, invest in its business for sustainable growth, optimize debt, and deliver shareholder returns.

Disclaimer*

Aberdeen Group PLC
08 October 2026
 

8 October 2026

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO, OR FROM THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION.

THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING THE UNITED STATES.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

FOR IMMEDIATE RELEASE.

Aberdeen Group plc ("Aberdeen" or the "Company")

Result of Secondary Placing in Standard Life plc

Aberdeen announces that it has sold an aggregate of 52,000,000 ordinary shares (the "Placing Shares") in Standard Life plc ("Standard Life"), representing approximately 5.2% of Standard Life's issued share capital, at a price of 839 pence per share (the "Placing"), raising aggregate gross sale proceeds of approximately £436 million.

Following settlement of the Placing, which is expected to take place on 12 October 2026, Aberdeen's residual shareholding will represent approximately 5.2% of Standard Life's issued share capital.

Aberdeen intends to deploy the proceeds from the Placing in accordance with its disciplined capital allocation policy, which is focused on maintaining a strong balance sheet, investing selectively in the business to support sustainable profitable growth, reducing and optimising debt over time, and delivering sustainable returns to shareholders.

Evercore Partners International LLP is acting as lead financial adviser to Aberdeen in connection with the Placing. Goldman Sachs International and J.P. Morgan Securities plc, which conducts its UK investment banking activities as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), have been appointed by the Company as Joint Global Coordinators and Bookrunners for the Placing.

Standard Life was not a party to the Placing and will not receive any proceeds or shares in connection with the Placing.

 

Enquiries:


Aberdeen Group plc


Duncan Young (External Communications Director)

+44 (0) 7920 868 865

Duncan Heath (Investor Relations Director)

+44 (0) 207 156 2495

 

Evercore Partners International LLP

+44 (0) 207 653 6000

Chetan Singh


Lyle Schwartz


 

Goldman Sachs International

+44 (0) 207 774 1000

Richard Cormack

Charlie Lytle 


 

J.P. Morgan Cazenove

+44 (0) 207 742 4000

Ed Squire


Will Holyoak


 

Important notices:

Inside information

This announcement contains inside information as stipulated under the Market Abuse Regulation No. 596/2014 (as it forms part of the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended)). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for making this announcement on behalf of Aberdeen is Iain Jones.

Other

This announcement has been issued by and is the sole responsibility of the Company.

This announcement is for information purposes only and is not intended to and does not constitute an offer to sell, or the solicitation of an offer to subscribe for or buy, any shares nor any other securities in any jurisdiction. Shares will not be generally made available or marketed to the public in the United Kingdom or any other jurisdiction in connection with the Placing.

Overseas jurisdictions

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction.

In particular, the securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and may not be offered, sold or transferred, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with all applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of any securities in the United States.

Disclaimer

Evercore Partners International LLP ("Evercore"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as financial adviser to Aberdeen and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than Aberdeen for providing the protections afforded to clients of Evercore nor for providing advice in connection with the matters referred to herein. Neither Evercore nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Evercore in connection with this announcement, any statement contained herein, any offer or otherwise. Apart from the responsibilities and liabilities, if any, which may be imposed on Evercore by the Financial Services and Markets Act 2000, or the regulatory regime established thereunder, or under the regulatory regime of any jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither Evercore nor any of its subsidiaries, branches or affiliates accepts any responsibility or liability whatsoever for the contents of this announcement, and no representation, express or implied, is made by it, or purported to be made on its behalf, in relation to the contents of this announcement, including its accuracy, completeness or verification of any other statement made or purported to be made by it, or on its behalf, in connection with Aberdeen or the matters described in this document. To the fullest extent permitted by applicable law, Evercore and its affiliates accordingly disclaim all and any responsibility or liability whether arising in tort, contract or otherwise (save as referred to above) which they might otherwise have in respect of this announcement, or any statement contained herein.

Goldman Sachs International ("GSI"), which is authorised in the United Kingdom by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, is acting for the Company and no-one else in connection with the Placing. Neither GSI nor its affiliates, nor their respective partners, directors, officers, employees or agents are responsible to anyone other than the Company for providing the protections afforded to clients of GSI or providing advice in relation to the Placing or any other matter referred to in this announcement.

J.P. Morgan Securities plc ("JPM"), which is authorised in the United Kingdom by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, is acting for the Company and no-one else in connection with the Placing. Neither JPM nor its affiliates, nor their respective partners, directors, officers, employees or agents are responsible to anyone other than the Company for providing the protections afforded to clients of JPM or providing advice in relation to the Placing or any other matter referred to in this announcement.

This announcement does not constitute a recommendation to participate in the Placing. The price and value of securities and any income from them can go down as well as up. Past performance is not a guide to future performance. Acquiring shares may expose an investor to a significant risk of losing all of the amount invested. Potential investors should consult an independent financial advisor as to the suitability of the Placing for the entity or person concerned. The Company reserves the right not to proceed with the Placing or to vary the terms of the Placing in any way.

Forward-looking statements

This announcement includes statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "intends", "expects", "will", or "may", or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and include statements regarding intentions, beliefs or current expectations. No assurances can be given that the forward-looking statements in this announcement will be realised. As a result, no undue reliance should be placed on these forward-looking statements as a prediction of actual events or otherwise.

LEI number of Aberdeen Group plc: 0TMBS544NMO7GLCE7H90

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings